Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors.
Anne MenzTimo WeitbrechtNatalia GorbokonFranziska BüscheckAndreas M LuebkeMartina KluthClaudia Hube-MaggAndrea HinschDoris HöflmayerSören WeidemannChristoph FrauneKatharina MöllerChristian BernreutherPatrick LebokTill ClauditzGuido SauterRia UhligWaldemar WilczakStefan SteurerSarah MinnerEike BurandtRainer KrechDavid DumTill KrechAndreas MarxRonald SimonPublished in: Molecular medicine (Cambridge, Mass.) (2021)
Down-regulation or loss of CK18 expression in cancers arising from CK18 positive tissues as well as CK18 neo-expression in cancers originating from CK18 negative tissues is linked to cancer progression and may reflect tumor dedifferentiation.